What the FDA labels say about taking them together
Lithium and nabumetone
Nabumetone's FDA label of January 13, 2025 names lithium in its drug interactions section; lithium's label does not name nabumetone itself but warns about its class (NSAIDs (nonsteroidal anti-inflammatory drugs)). The nabumetone label: “NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance.”
Check it at the source: the lithium FDA label on DailyMed (effective December 23, 2025, Glenmark Pharmaceuticals Inc., USA); the nabumetone FDA label on DailyMed (effective January 13, 2025, ScieGen Pharmaceuticals Inc).
What does the lithium label say about nabumetone?
Lithium's label does not name nabumetone itself; it warns about its class (NSAIDs (nonsteroidal anti-inflammatory drugs)):
Lithium label, drug interactionsDiuretics, NSAID, renin-angiotensin system antagonists, or metronidazole may increase lithium serum concentrations.
Lithium label, drug interactionsReduce lithium dosage based on serum lithium concentration and clinical response [see Dosage and Administration ( 2.3 ), Warning and Precautions ( 5.3 )]. Non-Steroidal Anti-inflammatory Drugs (NSAID)
Source: FDA drug label (Lithium Carbonate), Glenmark Pharmaceuticals Inc., USA, effective December 23, 2025 (SPL set 63b3790f-a9b5-47f4-bae1-ddf8b43c13c1), via openFDA; the full label on DailyMed
What does the nabumetone label say about lithium?
Nabumetone label, drug interactionsNSAIDs have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance.
Source: FDA drug label (Nabumetone), ScieGen Pharmaceuticals Inc, effective January 13, 2025 (SPL set 80c6888d-03b4-44f3-b94d-bcf5154ceae5), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Lithium | Nabumetone | |
|---|---|---|
| Labeled for | Bipolar disorder | Osteoarthritis, Rheumatoid arthritis |
| Boxed warning | Yes | Yes |
| Pharmacy cost (NADAC) | $0.104 per capsule 300 mg capsule | $0.128 per tablet 500 mg tablet |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once